Skip to Content
Merck
All Photos(2)

Key Documents

209767

Sigma-Aldrich

2,2-Dichloro-1-methyl-cyclopropanecarboxylic acid

98%

Sign Into View Organizational & Contract Pricing


About This Item

Linear Formula:
Cl2C3H2(CH3)CO2H
CAS Number:
Molecular Weight:
169.01
Beilstein:
1937304
EC Number:
MDL number:
UNSPSC Code:
12352100
PubChem Substance ID:
NACRES:
NA.22

Quality Level

Assay

98%

form

solid

bp

85 °C/8 mmHg (lit.)

mp

60-65 °C (lit.)

SMILES string

CC1(CC1(Cl)Cl)C(O)=O

InChI

1S/C5H6Cl2O2/c1-4(3(8)9)2-5(4,6)7/h2H2,1H3,(H,8,9)

InChI key

BIUUWIKPBYWKEQ-UHFFFAOYSA-N

Looking for similar products? Visit Product Comparison Guide

Application

2,2-Dichloro-1-methyl-cyclopropanecarboxylic acid was used in solid phase synthesis of α-hydroxy esters, inhibitors of amyloid-β production.

Pictograms

Exclamation mark

Signal Word

Warning

Hazard Statements

Hazard Classifications

Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3

Target Organs

Respiratory system

Storage Class Code

11 - Combustible Solids

WGK

WGK 3

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Personal Protective Equipment

dust mask type N95 (US), Eyeshields, Gloves

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Owen B Wallace et al.
Bioorganic & medicinal chemistry letters, 13(6), 1203-1206 (2003-03-20)
Inhibitors of amyloid-beta (Abeta) protein production have been widely pursued as a potential treatment for Alzheimer's disease. Following the identification of a 5 microM screening hit, SAR was initiated using solid-phase synthetic techniques. Two series of alpha-hydroxy esters and ketones
Dmitriy Ovcharenko et al.
Cancer biology & therapy, 20(9), 1281-1289 (2019-06-27)
Dichloroacetate (DCA) is an inhibitor of pyruvate dehydrogenase kinase (PDK) that has been shown to reverse the Warburg effect and cause tumor cell death. Clinical research into the anti-cancer activity of DCA revealed high dosage requirements and reports of toxicity.

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service